We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAL
7351
DELISTED
Salisbury Bancorp, Inc.
SAL
-30
Closed -$1K
PDCE
7352
PUT
DELISTED
PDC Energy, Inc.
PDCE
-113,000
Closed -$5.53M
BBIG
7353
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-1
Closed
TDW.WS.A
7354
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$0 ﹤0.01%
28
TDW.WS.B
7355
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$0 ﹤0.01%
30
NMTR
7356
DELISTED
9 Meters Biopharma
NMTR
-347
Closed -$47K
ATTO
7357
DELISTED
Atento S.A.
ATTO
-2
Closed
NYMX
7358
DELISTED
Nymox Pharmaceutical Corp
NYMX
$0 ﹤0.01%
499
-11,801
-96% -$21.6K
EVLO
7359
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-101
Closed -$24K
ROCC
7360
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-1,833
Closed -$148K
HVBC
7361
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
-22
Closed
DCP
7362
PUT
DELISTED
DCP Midstream, LP
DCP
-1,900
Closed -$75K
DBD
7363
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
-4,100
Closed -$18K
KBAL
7364
DELISTED
Kimball International
KBAL
-14,999
Closed -$251K
BLCM
7365
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
6
-3,509
-100% -$156K
BIOC
7366
DELISTED
Biocept, Inc.
BIOC
0
VYNT
7367
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$0 ﹤0.01%
3
FRC
7368
PUT
DELISTED
First Republic Bank
FRC
-100
Closed -$10K
OIG
7369
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$0 ﹤0.01%
2
ASPU
7370
DELISTED
ASPEN GROUP, INC.
ASPU
-76
Closed -$1K
AIMC
7371
PUT
DELISTED
Altra Industrial Motion Corp
AIMC
-130,000
Closed -$5.37M
SIOX
7372
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$0 ﹤0.01%
50
+32
+178% +$461
ATNX
7373
DELISTED
Athenex, Inc. Common Stock
ATNX
-1,111
Closed -$345K
FFBW
7374
DELISTED
FFBW, Inc. Common Stock
FFBW
-15
Closed
HZN
7375
DELISTED
Horizon Global Corporation
HZN
-2,759
Closed -$20K

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.